Replay available

SCYNEXIS, Inc. (SCYX) Q2 2022 Earnings Call

SCYNEXIS, Inc. (NASDAQ: SCYX) Q2 2022 earnings conference call, held 2022-08-15. Replay captured from the company's public earnings webcast.

Mon, August 15, 2022 at 8:30 AMendedReplay
SCYNEXIS, Inc. (SCYX) Q2 2022 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Debbie Acheson

Communications and Investor Relations

Dr. Marco Taglietti

President and CEO

Christine Coyne

Chief Commercial Officer

Dr. David Angulo

Chief Medical Officer

Larry Hoffman

Interim Chief Financial Officer

Oren Lisnet

Analyst, H.C. Wainwright & Co.

Kumar Raja

Analyst, Brookline Capital Markets

Steve Brozek

Analyst, WBB Securities

Unknown Participant

Replay transcript excerpt

ladies and gentlemen good morning and welcome to the synexis inc second quarter 2022 earnings conference call at this time all participants are in a listen-only mode a question and answer session will follow the formal presentation if anyone should require operator assistance during the conference please press star 0 on your telephone keypad as a reminder this conference is being recorded I will now turn the conference over to Ms. Debbie Acheson, Communications and Investor Relations. Please go ahead. Thank you. Hello everyone, and welcome to today's conference call to discuss our second quarter 2022 financial results and corporate update. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook for the future. leadership expectations for our future financial and operational performance, as well as our business strategy. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Please refer to our filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K and quarterly report on Form 10-Q, included in each case under the caption, Risk Factors. and another document subsequently filed with or furnished to the Securities and Exchange Commission. All forward-looking statements speak only as of today, August 15, 2022. Cenexus undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. The information on today's call is not intended for promotional purposes and not sufficient for prescribing decisions. Joining us...

More from Scynexis, Inc.